Globus Medical (Globus Medical) Gross Profit : $1,020 Mil (TTM As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Globus Medical Gross Profit?

Globus Medical's gross profit for the three months ended in Dec. 2023 was $351 Mil. Globus Medical's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was $1,020 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Globus Medical's gross profit for the three months ended in Dec. 2023 was $351 Mil. Globus Medical's Revenue for the three months ended in Dec. 2023 was $617 Mil. Therefore, Globus Medical's Gross Margin % for the quarter that ended in Dec. 2023 was 56.94%.

Globus Medical had a gross margin of 56.94% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Globus Medical was 77.64%. The lowest was 65.05%. And the median was 75.92%.

Warning Sign:

Globus Medical Inc gross margin has been in long-term decline. The average rate of decline per year is -2.7%.

Globus Medical Gross Profit Historical Data

The historical data trend for Globus Medical's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Globus Medical Gross Profit Chart

Globus Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Profit

Get a 7-Day Free Trial

605.39

571.58

718.88

759.12

1,020.30

Globus Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross Profit	Get a 7-Day Free Trial															203.91	205.86	215.14	248.25	351.05

Competitive Comparison of Globus Medical's Gross Profit

For the Medical Devices subindustry, Globus Medical's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Globus Medical's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Gross Profit distribution charts can be found below:

* The bar in red indicates where Globus Medical's Gross Profit falls into.

Globus Medical Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Globus Medical's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	1568.476	-	548.174
	=	1,020

Globus Medical's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	616.534	-	265.486
	=	351

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,020 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Globus Medical's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	351	/	616.534
	=	56.94 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Globus Medical (NYSE:GMED) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Globus Medical had a gross margin of 56.94% for the quarter that ended in Dec. 2023 => Durable competitive advantage

Globus Medical Gross Profit Related Terms

Thank you for viewing the detailed overview of Globus Medical's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Globus Medical (Globus Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Globus Medical Inc (NYSE:GMED) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

GM0N:Germany

Address

2560 General Armistead Avenue, Audubon, PA, USA, 19403

Website

https://www.globusmedical.com

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

Executives

Leslie V Norwalk	director	C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Dan Wolterman	director	3721 VALLEY CENTRE DR, SUITE 500, SAN DIEGO CA 92130
John A Deford	director	C R BARD INC, 730 CENTRAL AVENUE, MURRAY HILL NJ 07974
Dan Lemaitre	director	2 MUSICK, IRVINE CA 92618
Keith W Pfeil	officer: SVP, Chief Financial Officer	GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Kelly Huller	officer: SVP, General Counsel	2560 GENERAL ARMISTEAD AVENUE, AUDOBON PA 19403
David D Davidar	director, officer: Vice President, Operations	C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
James R Tobin	director	C/O CURIS INC, 4 MAGUIRE ROAD, LEXINGTON MA 02421
Daniel T Scavilla	officer: Senior VP and CFO	C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
David M Demski	director, officer: President and COO	C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Robert Andrew Douglas	director	21 ATTUNGA ROAD, NEWPORT, NEW SOUTH WALES C3 2106
Stephen T Zarrilli	director	FIBERLINK COMMUNICATIONS CORP., 794 PENLLYN PIKE, BLUE BELL PA 19422
Anthony L Williams	officer: Senior VP of Bus. Devel. & GC	C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Steven Payne	officer: Chief Accounting Officer	C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
David C Paul	director, 10 percent owner, officer: Chief Executive Officer	C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403